The healthcare sector has been making headlines recently, with many calling for regulatory and systemic reforms 

as insurance premiums are expected to rise by up to 70% next year. As a result, the Health Ministry has proposed  that diagnosis-related group pricing system, (DRG) be implemented. Oong Chun Sung, Equity Research Analyst, RHB Investment Bank tells us if DRG will be a boom or bane for earnings and which listed companies stand to benefit.



Image Credits: Shutterstock.com

The healthcare sector has been making headlines recently, with many calling for regulatory and systemic reforms as insurance premiums are expected to rise by up to 70% next year. As a result, the Health Ministry has proposed that diagnosis-related group pricing system, (DRG) be implemented. Oong Chun Sung, Equity Research Analyst, RHB Investment Bank tells us if DRG will be a boom or bane for earnings and which listed companies stand&nbsp;to&nbsp;benefit.Image Credits: Shutterstock.com

Opinion and analysis of today’s international and local news that matter to Malaysians. Everything you need to know to start and plan your work.

Opinion and analysis of today&rsquo;s international and local news that matter to Malaysians. Everything you need to know to start and plan your work.

Advertisement